Archana Mishra

Dr. Archana Mishra

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2023 in European Journal of Haematology
Verified
Journal Article
Closed access
AMArchana Mishra
Archana Mishra
RMRituparna Maiti
Rituparna Maiti
PMPrafull Mohan
Prafull Mohan
PGPooja Gupta
Pooja Gupta


1 January 2020 in Journal of Clinical Neurology
Verified
Journal Article
Open access
AMArchana Mishra
Archana Mishra
RMRituparna Maiti
Rituparna Maiti
BMBiswa Ranjan Mishra
Biswa Ranjan Mishra
MJMonalisa Jena
Monalisa Jena
ASAnand Srinivasan
Anand Srinivasan
The role of low-frequency repetitive transcranial stimulation (rTMS) in drug-resistant epilepsy (DRE) has been conflicting and inconclusive in previous clinical trials. This meta-analysis evaluated the efficacy of rTMS on seizure frequency and epileptiform discharges in DRE. A standard meta-analysis protocol was registered in the International Prospective Register of Ongoing Systematic Reviews (PROSPERO: CRD42018088544). After performing a comprehensive literature search using specific keywords in MEDLINE, the Cochrane database, and the International Clinical Trial Registry Platform (ICTRP), reviewers assessed the eligibility and extracted data from seven relevant clinical trials. Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines were followed in the selection, analysis, and reporting of findings. A random-effects model was used to estimate the effect size as the mean difference in seizure frequency and interictal epileptiform discharges between the groups. Quality assessment was performed using a risk-of-bias assessment tool, and a meta-regression was used to identify the variables that probably influenced the effect size. The random-effects model analysis revealed a pooled effect size of -5.96 (95% CI= -8.98 to -2.94), significantly favoring rTMS stimulation (p=0.0001) over the control group with regard to seizure frequency. The overall effect size for interictal epileptiform discharges also significantly favored rTMS stimulation (p<0.0001), with an overall effect size of -9.36 (95% CI=-13.24 to -5.47). In the meta-regression, the seizure frequency worsened by 2.00±0.98 (mean±SD, p=0.042) for each week-long lengthening of the posttreatment follow-up period, suggesting that rTMS exerts only a short-term effect. This meta-analysis shows that rTMS exerts a significant beneficial effect on DRE by reducing both the seizure frequency and interictal epileptiform discharges. However, the meta-regression revealed only an ephemeral effect of rTMS.

1 May 2019 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
MJMonalisa Jena
Monalisa Jena
RRRajeev Ranjan
Rajeev Ranjan
BMBiswa Ranjan Mishra
Biswa Ranjan Mishra
AMArchana Mishra
Archana Mishra
SNSantanu Nath
Santanu Nath
RMRituparna Maiti
Rituparna Maiti

12 May 2023 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Closed access
RMRituparna Maiti
Rituparna Maiti
AMArchana Mishra
Archana Mishra
ASAnand Srinivasan
Anand Srinivasan
BMBiswa Ranjan Mishra
Biswa Ranjan Mishra

1 December 2017 in Epilepsy Research
Verified
Journal Article
Closed access
RMRituparna Maiti
Rituparna Maiti
BMBiswa Ranjan Mishra
Biswa Ranjan Mishra
SSSoham Sanyal
Soham Sanyal
DMDebadatta Mohapatra
Debadatta Mohapatra
SPSansita Parida
Sansita Parida
AMArchana Mishra
Archana Mishra